Decisions on drug therapies by numbers needed to treat: A randomized trial

Archives of Internal Medicine

Volumn 165, Issue 10, 2005, Pages 1140-1146

  Halvorsen, Peder Andreas ^a,c   Kristiansen, Ivar Sønbø ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF OSLO   (Norway)

^c NONE   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; HYDROCHLOROTHIAZIDE; METOPROLOL; SIMVASTATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; HEART INFARCTION; HIP FRACTURE; HUMAN; MEDICAL DECISION MAKING; NORWAY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STROKE;

ADOLESCENT; ADULT; AGED; CEREBROVASCULAR ACCIDENT; COMPREHENSION; DECISION MAKING; DRUG COSTS; DRUG THERAPY; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; QUESTIONNAIRES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 19344372967     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.165.10.1140     Document Type: Article

References (27)

1. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318:1728-1733.
2. Riegelman R, Schroth WS. Adjusting the number needed to treat: incorporating adjustments for the utility and timing of benefits and harms. Med Decis Making. 1993;13:247-252.
3. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452-454.
4. Rajkumar SV, Sampathkumar P, Gustafson AB. Number needed to treat is a simple measure of treatment efficacy for clinicians. J Gen Intern Med. 1996;11:357-359.
5. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. Number needed to treat: easily understood and intuitively meaningful? theoretical considerations and a randomized trial. J Clin Epidemiol. 2002;55:888-892.
6. Christensen PM, Brosen K, Brixen K, Andersen M, Kristiansen IS. A randomised trial of laypersons' perception of the benefit from osteoporosis therapy: number needed to treat versus postponement of hip fracture. Clin Ther. 2003;25:2575-2585.
7. Halvorsen PA, Kristiansen IS, Aasland OG, Forde OH, Medical doctors' perception of the "number needed to treat" (NNT): a survey of doctors' recommendations for two therapies with different NNT. Scand J Prim Health Care. 2003;21:162-166.
8. San Laureano JA, Briganti EM, Colville DJ. Number needed to treat: a useful new method of assessing the magnitude of treatment effect and its application to the management of diabetic retinopathy. Aust N Z J Ophthalmol. 1999;27:137-142.
9. Statistics Norway. Statistical Yearbook of Noway 2003. Oslo: Statistics Norway; 2003.
10. Altman DG. Confidence intervals for the number needed to treat. BMJ. 1998;317: 1309-1312.
11. Lesaffre E, Pledger G. A note on the number needed to treat. Control Clin Trials. 1999;20:439-447.
12. Hutton JL. Number needed to treat: properties and problems. J R Stat Soc Ser A Stat Soc. 2000;163:381-402.
13. Dowie J. The "number needed to treat" and the "adjusted NNT" in health care decision-making. J Health Serv Res Policy. 1998;3:44-49.
14. Fahey T, Montgomery AA, Peters TJ. Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]. BMC Health Serv Res. 2001;1:10.
15. Misselbrook D, Armstrong D. Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract. 2001;51:276-279.
16. Cranney M, Walley T, Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract. 1996;46:661-663.
17. Nexoe J, Gyrd-Hansen D, Kragstrup J, Kristiansen IS, Nielsen JB. Danish GPs' perception of disease risk and benefit of prevention. Fam Pract. 2002;19:3-6.
18. Nexoe J, Oltarzewska AM, Sawicka-Powierza J, Kragstrup J, Kristiansen IS. Perception of risk information: similarities and differences between Danish and Polish general practitioners. Scand J Prim Health Care. 2002;20:183-187.
19. Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ. 1995;311:1056-1059.
20. Nexøe J, Kristiansen IS, Gyrd-Hansen D, Nielsen JB. Influence of number needed to treat, cost and outcome on preferences for a preventive drug. Fam Pract 2005;22:126-131.
21. Lloyd AJ. The extent of patients' understanding of the risk of treatments. Qual Health Care. 2001;10(suppl 1):i14-i18.
22. Rottenstreich Y, Hsee CK. Money, kisses, and electric shocks: on the affective psychology of risk. Psychol Sci. 2001;12:185-190.
23. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997;127:966-972.
24. Sheridan SL, Pignone M. Numeracy and the medical student's ability to interpret data. Eff Clin Pract. 2002;5:35-40.
25. Sheridan SL, Pignone MP, Lewis CL. A randomized comparison of patients' understanding of number needed to treat and other common risk reduction formats. J Gen Intern Med. 2003;18:884-892.
26. Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ. 2003;327:741-744.
27. Kristiansen IS. Communicating the effect of risk interventions in terms of postponement of adverse effect [abstract]. Med Decis Making. 2004;24:422.